AMERICAN HEALTHCARE REIT INC (AHR) Fundamental Analysis & Valuation

NYSE:AHR • US3981823038

Current stock price

50.78 USD
+0.57 (+1.14%)
At close:
50.78 USD
0 (0%)
After Hours:

This AHR fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

4

1. AHR Profitability Analysis

1.1 Basic Checks

  • In the past year AHR was profitable.
  • In the past year AHR had a positive cash flow from operations.
  • The reported net income has been mixed in the past 5 years: AHR reported negative net income in multiple years.
  • In the past 5 years AHR always reported a positive cash flow from operatings.
AHR Yearly Net Income VS EBIT VS OCF VS FCFAHR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 100M -100M -200M

1.2 Ratios

  • AHR's Return On Assets of -0.23% is on the low side compared to the rest of the industry. AHR is outperformed by 60.33% of its industry peers.
  • AHR has a worse Return On Equity (-0.95%) than 60.33% of its industry peers.
  • AHR has a Return On Invested Capital (3.05%) which is in line with its industry peers.
  • AHR had an Average Return On Invested Capital over the past 3 years of 2.69%. This is in line with the industry average of 3.11%.
  • The last Return On Invested Capital (3.05%) for AHR is above the 3 year average (2.69%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA -0.23%
ROE -0.95%
ROIC 3.05%
ROA(3y)0.2%
ROA(5y)0.79%
ROE(3y)0.69%
ROE(5y)2.74%
ROIC(3y)2.69%
ROIC(5y)2.5%
AHR Yearly ROA, ROE, ROICAHR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 5 10 15

1.3 Margins

  • AHR has a Operating Margin (28.52%) which is comparable to the rest of the industry.
  • AHR's Operating Margin has improved in the last couple of years.
  • AHR has a Gross Margin (67.74%) which is comparable to the rest of the industry.
  • In the last couple of years the Gross Margin of AHR has grown nicely.
Industry RankSector Rank
OM 28.52%
PM (TTM) N/A
GM 67.74%
OM growth 3Y26.16%
OM growth 5Y20.2%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y25.89%
GM growth 5Y17.28%
AHR Yearly Profit, Operating, Gross MarginsAHR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 40 60

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

1

2. AHR Health Analysis

2.1 Basic Checks

  • AHR has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
  • Compared to 1 year ago, AHR has more shares outstanding
  • The number of shares outstanding for AHR has been increased compared to 5 years ago.
  • The debt/assets ratio for AHR is higher compared to a year ago.
AHR Yearly Shares OutstandingAHR Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M
AHR Yearly Total Debt VS Total AssetsAHR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B 2B 2.5B

2.2 Solvency

  • Based on the Altman-Z score of 1.48, we must say that AHR is in the distress zone and has some risk of bankruptcy.
  • AHR has a Altman-Z score of 1.48. This is amongst the best in the industry. AHR outperforms 88.43% of its industry peers.
  • A Debt/Equity ratio of 1.91 is on the high side and indicates that AHR has dependencies on debt financing.
  • AHR's Debt to Equity ratio of 1.91 is on the low side compared to the rest of the industry. AHR is outperformed by 67.77% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.91
Debt/FCF N/A
Altman-Z 1.48
ROIC/WACC0.39
WACC7.9%
AHR Yearly LT Debt VS Equity VS FCFAHR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 500M 1B

2.3 Liquidity

  • A Current Ratio of 0.24 indicates that AHR may have some problems paying its short term obligations.
  • Looking at the Current ratio, with a value of 0.24, AHR is doing worse than 88.43% of the companies in the same industry.
  • A Quick Ratio of 0.23 indicates that AHR may have some problems paying its short term obligations.
  • With a Quick ratio value of 0.23, AHR is not doing good in the industry: 85.12% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 0.24
Quick Ratio 0.23
AHR Yearly Current Assets VS Current LiabilitesAHR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M 400M 500M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

5

3. AHR Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an nice 11.76% over the past year.
  • Looking at the last year, AHR shows a very negative growth in Revenue. The Revenue has decreased by -59.74% in the last year.
  • AHR shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -5.76% yearly.
EPS 1Y (TTM)11.76%
EPS 3Y-25.79%
EPS 5Y0%
EPS Q2Q%11.54%
Revenue 1Y (TTM)-59.74%
Revenue growth 3Y-14.37%
Revenue growth 5Y-5.76%
Sales Q2Q%-86.74%

3.2 Future

  • Based on estimates for the next years, AHR will show a very strong growth in Earnings Per Share. The EPS will grow by 44.28% on average per year.
  • The Revenue is expected to grow by 78.98% on average over the next years. This is a very strong growth
EPS Next Y-67.79%
EPS Next 2Y-32.45%
EPS Next 3Y44.28%
EPS Next 5YN/A
Revenue Next Year4.97%
Revenue Next 2Y5.36%
Revenue Next 3Y4.37%
Revenue Next 5Y78.98%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
  • The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
AHR Yearly Revenue VS EstimatesAHR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 1B 2B 3B 4B 5B
AHR Yearly EPS VS EstimatesAHR Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 0 0.2 0.4 0.6 0.8 1

More info and screens

Find the best growth stocksShow best growing peers

1

4. AHR Valuation Analysis

4.1 Price/Earnings Ratio

  • A Price/Earnings ratio of 133.63 indicates a quite expensive valuation of AHR.
  • The rest of the industry has a similar Price/Earnings ratio as AHR.
  • AHR's Price/Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 26.77.
  • With a Price/Forward Earnings ratio of 414.87, AHR can be considered very expensive at the moment.
  • Compared to the rest of the industry, the Price/Forward Earnings ratio of AHR is on the same level as its industry peers.
  • When comparing the Price/Forward Earnings ratio of AHR to the average of the S&P500 Index (21.75), we can say AHR is valued expensively.
Industry RankSector Rank
PE 133.63
Fwd PE 414.87
AHR Price Earnings VS Forward Price EarningsAHR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 100 200 300 400

4.2 Price Multiples

  • 91.74% of the companies in the same industry are cheaper than AHR, based on the Enterprise Value to EBITDA ratio.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 39.21
AHR Per share dataAHR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6

4.3 Compensation for Growth

  • AHR's earnings are expected to grow with 44.28% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-32.45%
EPS Next 3Y44.28%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

1

5. AHR Dividend Analysis

5.1 Amount

  • AHR has a Yearly Dividend Yield of 1.98%.
  • Compared to an average industry Dividend Yield of 7.44, AHR's dividend is way lower than its industry peers. On top of this 85.95% of the companies listed in the same industry pay a better dividend than AHR!
  • Compared to an average S&P500 Dividend Yield of 1.82, AHR has a dividend comparable with the average S&P500 company.
Industry RankSector Rank
Dividend Yield 1.98%

5.2 History

  • AHR has paid a dividend for less than 5 years, so there is no long track record yet.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years1
AHR Yearly Dividends per shareAHR Yearly Dividends per shareYearly Dividends per share 2024 2025 2026 0.2 0.4 0.6 0.8

5.3 Sustainability

  • The earnings of AHR are negative and hence is the payout ratio. AHR will probably not be able to sustain this dividend level.
DP-1265.55%
EPS Next 2Y-32.45%
EPS Next 3Y44.28%
AHR Yearly Income VS Free CF VS DividendAHR Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -100M -200M

More info and screens

Find the best dividend stocksShow peers with best dividend

AHR Fundamentals: All Metrics, Ratios and Statistics

AMERICAN HEALTHCARE REIT INC

NYSE:AHR (4/30/2026, 8:04:00 PM)

After market: 50.78 0 (0%)

50.78

+0.57 (+1.14%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryDiversified REITs
Industry Strength41.61
Industry Growth29.81
Earnings (Last)02-16
Earnings (Next)05-07
Inst Owners77.28%
Inst Owner Change0.33%
Ins Owners0.65%
Ins Owner Change-0.31%
Market Cap5.26B
Revenue(TTM)285.20M
Net Income(TTM)-5.94M
Analysts80
Price Target62.68 (23.43%)
Short Float %15.91%
Short Ratio5.01
Dividend
Industry RankSector Rank
Dividend Yield 1.98%
Yearly Dividend1.08
Dividend Growth(5Y)N/A
DP-1265.55%
Div Incr Years0
Div Non Decr Years1
Ex-Date03-31
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)211.82%
Min EPS beat(2)-187.15%
Max EPS beat(2)610.78%
EPS beat(4)2
Avg EPS beat(4)120.69%
Min EPS beat(4)-345.1%
Max EPS beat(4)610.78%
EPS beat(8)4
Avg EPS beat(8)192.99%
EPS beat(12)5
Avg EPS beat(12)80.89%
EPS beat(16)9
Avg EPS beat(16)93.59%
Revenue beat(2)2
Avg Revenue beat(2)1.69%
Min Revenue beat(2)0.58%
Max Revenue beat(2)2.79%
Revenue beat(4)4
Avg Revenue beat(4)366.94%
Min Revenue beat(4)0.58%
Max Revenue beat(4)738.85%
Revenue beat(8)8
Avg Revenue beat(8)532.61%
Revenue beat(12)12
Avg Revenue beat(12)450.59%
Revenue beat(16)16
Avg Revenue beat(16)365.86%
PT rev (1m)9.58%
PT rev (3m)9.56%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)-100%
EPS NY rev (1m)0%
EPS NY rev (3m)-83.26%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-89.02%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-88.66%
Valuation
Industry RankSector Rank
PE 133.63
Fwd PE 414.87
P/S 18.46
P/FCF N/A
P/OCF 81.95
P/B 8.39
P/tB 9.57
EV/EBITDA 39.21
EPS(TTM)0.38
EY0.75%
EPS(NY)0.12
Fwd EY0.24%
FCF(TTM)-0.25
FCFYN/A
OCF(TTM)0.62
OCFY1.22%
SpS2.75
BVpS6.05
TBVpS5.31
PEG (NY)N/A
PEG (5Y)N/A
Graham Number7.19512 (-85.83%)
Profitability
Industry RankSector Rank
ROA -0.23%
ROE -0.95%
ROCE 3.86%
ROIC 3.05%
ROICexc 3.13%
ROICexgc 3.34%
OM 28.52%
PM (TTM) N/A
GM 67.74%
FCFM N/A
ROA(3y)0.2%
ROA(5y)0.79%
ROE(3y)0.69%
ROE(5y)2.74%
ROIC(3y)2.69%
ROIC(5y)2.5%
ROICexc(3y)2.76%
ROICexc(5y)2.56%
ROICexgc(3y)2.95%
ROICexgc(5y)2.74%
ROCE(3y)3.4%
ROCE(5y)3.17%
ROICexgc growth 3Y6.79%
ROICexgc growth 5Y8.56%
ROICexc growth 3Y7.57%
ROICexc growth 5Y8.47%
OM growth 3Y26.16%
OM growth 5Y20.2%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y25.89%
GM growth 5Y17.28%
F-Score5
Asset Turnover0.11
Health
Industry RankSector Rank
Debt/Equity 1.91
Debt/FCF N/A
Debt/EBITDA 6.94
Cap/Depr 98.96%
Cap/Sales 31.75%
Interest Coverage 1.11
Cash Conversion 37.18%
Profit Quality N/A
Current Ratio 0.24
Quick Ratio 0.23
Altman-Z 1.48
F-Score5
WACC7.9%
ROIC/WACC0.39
Cap/Depr(3y)86.46%
Cap/Depr(5y)148.77%
Cap/Sales(3y)29.96%
Cap/Sales(5y)37.05%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)11.76%
EPS 3Y-25.79%
EPS 5Y0%
EPS Q2Q%11.54%
EPS Next Y-67.79%
EPS Next 2Y-32.45%
EPS Next 3Y44.28%
EPS Next 5YN/A
Revenue 1Y (TTM)-59.74%
Revenue growth 3Y-14.37%
Revenue growth 5Y-5.76%
Sales Q2Q%-86.74%
Revenue Next Year4.97%
Revenue Next 2Y5.36%
Revenue Next 3Y4.37%
Revenue Next 5Y78.98%
EBIT growth 1Y-12.01%
EBIT growth 3Y8.03%
EBIT growth 5Y13.28%
EBIT Next Year171.97%
EBIT Next 3Y39.68%
EBIT Next 5YN/A
FCF growth 1Y-150.74%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-42.65%
OCF growth 3Y-18.09%
OCF growth 5Y-6.77%

AMERICAN HEALTHCARE REIT INC / AHR Fundamental Analysis FAQ

What is the ChartMill fundamental rating of AMERICAN HEALTHCARE REIT INC (AHR) stock?

ChartMill assigns a fundamental rating of 3 / 10 to AHR.


What is the valuation status of AMERICAN HEALTHCARE REIT INC (AHR) stock?

ChartMill assigns a valuation rating of 1 / 10 to AMERICAN HEALTHCARE REIT INC (AHR). This can be considered as Overvalued.


How profitable is AMERICAN HEALTHCARE REIT INC (AHR) stock?

AMERICAN HEALTHCARE REIT INC (AHR) has a profitability rating of 4 / 10.


What is the valuation of AMERICAN HEALTHCARE REIT INC based on its PE and PB ratios?

The Price/Earnings (PE) ratio for AMERICAN HEALTHCARE REIT INC (AHR) is 133.63 and the Price/Book (PB) ratio is 8.39.


What is the financial health of AMERICAN HEALTHCARE REIT INC (AHR) stock?

The financial health rating of AMERICAN HEALTHCARE REIT INC (AHR) is 1 / 10.